Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.
about
Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma.Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant diseaseClinical Trials in Pancreatic Cancer: A Long Slog.Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial.Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer.Exome-Wide Association Study of Pancreatic Cancer Risk.Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.Molecular landscape of pancreatic cancer: challenges and clinical implications.Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment.Prediction of pancreatic cancer risk and therapeutic response with next-generation sequencing.PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker.Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.DNA repair defects and implications for immunotherapy
P2860
Q41039836-AF5AEB17-6FFE-414B-95E0-B3AC4B1557BAQ41093656-AE64FE95-1E68-406B-BFEF-AB70D38FB015Q47095955-F915F4C7-C7A5-46B9-BD41-FA08696EA7A6Q47232401-7383A5A1-E1EA-45FF-B6FB-A1B36B486580Q47701712-39349890-3926-4FFA-92A7-D1849ADF8190Q47710148-516927B5-88F1-4FE2-A413-F6C2A4C35134Q47713578-9EFCAD7E-5397-4652-B80E-56D5E1ECBA5DQ47813912-B856B365-D1A4-4772-83D2-2A481F02E2F2Q49787327-FC384A65-25AB-4F7A-B29C-21ED679D1151Q49858111-2F55120F-A931-4821-89A8-69C8E5583241Q50203906-8632A079-4B9E-40EA-A9C0-AA27C27D51FAQ52739894-1AAD391F-6E84-4BA9-A96E-FCC3C012527AQ54277914-839EDC93-DE82-4DA8-98F3-F0E90A36BB04Q55104265-F11B4661-27ED-4A67-8ABD-2E7123534112Q57057014-968CA50E-1C8B-46AF-B55E-BE1493CC7287
P2860
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Association of Distinct Mutati ...... creatic Ductal Adenocarcinoma.
@en
Association of Distinct Mutati ...... creatic Ductal Adenocarcinoma.
@nl
type
label
Association of Distinct Mutati ...... creatic Ductal Adenocarcinoma.
@en
Association of Distinct Mutati ...... creatic Ductal Adenocarcinoma.
@nl
prefLabel
Association of Distinct Mutati ...... creatic Ductal Adenocarcinoma.
@en
Association of Distinct Mutati ...... creatic Ductal Adenocarcinoma.
@nl
P2093
P2860
P50
P1433
P1476
Association of Distinct Mutati ...... creatic Ductal Adenocarcinoma.
@en
P2093
Aaron Pollett
Alana Sherker
Ashton A Connor
Daniel Durocher
Daniel Palmer
Faiyaz Notta
Gavin W Wilson
Gloria Petersen
Gun Ho Jang
Ilinca M Lungu
P2860
P304
P356
10.1001/JAMAONCOL.2016.3916
P50
P577
2017-06-01T00:00:00Z